Bright Minds Biosciences to Present Data at the American Epilepsy Society 2024 Annual Meeting
HT2C functional selectivity and Phase 1 clinical data - NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Inc. (NASDAQ: DRUG), a ...